Although the in vitro study showed that celecoxib had a higher inhibitory effect on T24 cell growth than did etodolac, the in vivo study showed that etodolac most highly inhibited the T24 tumour growth among the three Cox-2 inhibitors (Figure 7A). The gene discussed is PTGS2; the disease is neoplasm.